Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Tumor necrosis factor-alpha polymorphism and susceptibility to multiple sclerosis in the Iranian population.
[The use of therapeutic apheresis in neurological diseases and comparison between plasma exchange and immunoadsorption].
Stem cell therapy in multiple sclerosis: a future perspective.
Paradoxical Effect of Cortistatin Treatment and Its Deficiency on Experimental Autoimmune Encephalomyelitis.
Fibroblast Growth Factor-2 Signaling in Neurogenesis and Neurodegeneration.
The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica.
CD226 ligation protects against EAE by promoting IL-10 expression via regulation of CD4+ T cell differentiation.
The therapeutic use of cannabinoids: Forensic aspects.
Role of TRIF Small Interference RNA (siRNA) in Chronic Experimental Allergic Encephalomyelitis (EAE).
High-resolution T1-relaxation time mapping displays subtle, clinically relevant, gray matter damage in long-standing multiple sclerosis.
Nanoparticle-Based and Bioengineered Probes and Sensors to Detect Physiological and Pathological Biomarkers in Neural Cells.
Reactivation of herpesvirus under fingolimod: A case of severe herpes simplex encephalitis.
Anti-MOG antibodies with longitudinally extensive transverse myelitis preceded by CLIPPERS.
Mechanisms of Antioxidant Induction with High-Dose N-Acetylcysteine in Childhood Cerebral Adrenoleukodystrophy.
Eye-Mediated Induction of Specific Immune Tolerance to Encephalitogenic Antigens.
Plasma Exchange for Steroid-Refractory Relapses in Multiple Sclerosis: An Observational, MRI Pilot Study.
An exploratory study on the spatial relationship between regional cortical volume changes and white matter integrity in Multiple Sclerosis.
Incidence of multiple sclerosis among European Economic Area populations, 1985-2009: the framework for monitoring.
Small non-coding RNA signature in multiple sclerosis patients after treatment with interferon-beta.
Brain atrophy: an in-vivo measure of disease activity in multiple sclerosis.
Magnetic resonance spectroscopic findings of chronic lesions in two subtypes of multiple sclerosis: primary progressive versus relapsing remitting.
Interleukin-1β and Interleukin-1 Receptor Antagonist Appear in Grey Matter Additionally to White Matter Lesions during Experimental Multiple Sclerosis.
A program to facilitate retention of employment among persons with multiple sclerosis.
Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE.
Immune Tolerance Induction against Experimental Autoimmune Encephalomyelitis (EAE) Using A New PLP-B7AP Conjugate that Simultaneously Targets B7/CD28 Costimulatory Signal and TCR/MHC-II Signal.

Pages